Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Novo Nordisk A-SNVO34.9612.2427.480.4488.73%32.91%37.29$107.54$389.6972,871$105.07

Detail of Novo Nordisk A-S

 
CEO
Mr. Lars Fruergaard Jorgensen
Employees
71880
Industry
Drug Manufacturers - General
Sector
Healthcare
Market cap
$3,311B

Company details

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OTH
OI
PI
TAX
NI
Revenue (Rev)
$270.58B
Cost of goods (CoG)
-$41.51B
Gross profit (GP)
$229.07B
Operating expense (OE)
-$110.70B
Research and development (R&D)
-$44.72B
General and administrative (G&A)
-$65.72B
Other (OTH)
-$261.00M
Operating income (OI)
$118.37B
Pretax income (PI)
$119.25B
Tax (TAX)
-$24.53B
Net income (NI)
$94.72B
Novo Nordisk A-S
NVO • XNYS • US
$105.07
+8.41 (8.70%)
Stock vs Industry average
  • Industry average

Dividend yield
1.37%
Trailing annual dividend rate
$9.90
Payout ratio
46.73%
EPS
$3.01
Margin profit
35.01%
52 week low
$97.099998
52 week high
$146.910004
50-day simple moving average
$103.75
200-day simple moving average
$107.54
Percent held by insiders
0.00%
Percent held by institutions
10.17%
Dividend yield
9.27%

Change of shares

Cash vs Debt

Comparison of selected companies

 
%
Price change
NVO +8.70%
eps change
NVO +22.11%